rs2280465

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001369268.1(ACAN):​c.7631-7G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.217 in 1,595,604 control chromosomes in the GnomAD database, including 38,239 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.20 ( 3219 hom., cov: 32)
Exomes 𝑓: 0.22 ( 35020 hom. )

Consequence

ACAN
NM_001369268.1 splice_region, intron

Scores

2
Splicing: ADA: 0.0001136
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -6.04

Publications

12 publications found
Variant links:
Genes affected
ACAN (HGNC:319): (aggrecan) This gene is a member of the aggrecan/versican proteoglycan family. The encoded protein is an integral part of the extracellular matrix in cartilagenous tissue and it withstands compression in cartilage. Mutations in this gene may be involved in skeletal dysplasia and spinal degeneration. Multiple alternatively spliced transcript variants that encode different protein isoforms have been observed in this gene. [provided by RefSeq, Jul 2008]
ACAN Gene-Disease associations (from GenCC):
  • osteochondritis dissecans
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Illumina, Orphanet
  • short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • spondyloepiphyseal dysplasia, Kimberley type
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • spondyloepimetaphyseal dysplasia, aggrecan type
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Orphanet
  • short stature-advanced bone age-early-onset osteoarthritis syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 15-88874398-G-A is Benign according to our data. Variant chr15-88874398-G-A is described in ClinVar as Benign. ClinVar VariationId is 1188850.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.222 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACANNM_001369268.1 linkc.7631-7G>A splice_region_variant, intron_variant Intron 18 of 18 ENST00000560601.4 NP_001356197.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACANENST00000560601.4 linkc.7631-7G>A splice_region_variant, intron_variant Intron 18 of 18 3 NM_001369268.1 ENSP00000453581.2 H0YMF1

Frequencies

GnomAD3 genomes
AF:
0.203
AC:
30753
AN:
151700
Hom.:
3209
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.177
Gnomad AMI
AF:
0.355
Gnomad AMR
AF:
0.214
Gnomad ASJ
AF:
0.275
Gnomad EAS
AF:
0.102
Gnomad SAS
AF:
0.199
Gnomad FIN
AF:
0.159
Gnomad MID
AF:
0.241
Gnomad NFE
AF:
0.225
Gnomad OTH
AF:
0.213
GnomAD2 exomes
AF:
0.201
AC:
44585
AN:
222244
AF XY:
0.204
show subpopulations
Gnomad AFR exome
AF:
0.172
Gnomad AMR exome
AF:
0.191
Gnomad ASJ exome
AF:
0.264
Gnomad EAS exome
AF:
0.0934
Gnomad FIN exome
AF:
0.160
Gnomad NFE exome
AF:
0.223
Gnomad OTH exome
AF:
0.228
GnomAD4 exome
AF:
0.218
AC:
314693
AN:
1443786
Hom.:
35020
Cov.:
32
AF XY:
0.218
AC XY:
156455
AN XY:
716686
show subpopulations
African (AFR)
AF:
0.180
AC:
5937
AN:
33034
American (AMR)
AF:
0.192
AC:
8119
AN:
42326
Ashkenazi Jewish (ASJ)
AF:
0.269
AC:
6936
AN:
25792
East Asian (EAS)
AF:
0.0858
AC:
3337
AN:
38912
South Asian (SAS)
AF:
0.214
AC:
17774
AN:
83178
European-Finnish (FIN)
AF:
0.162
AC:
8466
AN:
52258
Middle Eastern (MID)
AF:
0.281
AC:
1598
AN:
5692
European-Non Finnish (NFE)
AF:
0.226
AC:
249346
AN:
1102876
Other (OTH)
AF:
0.221
AC:
13180
AN:
59718
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
12395
24790
37185
49580
61975
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8584
17168
25752
34336
42920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.203
AC:
30778
AN:
151818
Hom.:
3219
Cov.:
32
AF XY:
0.202
AC XY:
15017
AN XY:
74192
show subpopulations
African (AFR)
AF:
0.177
AC:
7311
AN:
41396
American (AMR)
AF:
0.213
AC:
3254
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.275
AC:
953
AN:
3466
East Asian (EAS)
AF:
0.102
AC:
524
AN:
5130
South Asian (SAS)
AF:
0.199
AC:
954
AN:
4790
European-Finnish (FIN)
AF:
0.159
AC:
1681
AN:
10558
Middle Eastern (MID)
AF:
0.238
AC:
70
AN:
294
European-Non Finnish (NFE)
AF:
0.225
AC:
15248
AN:
67916
Other (OTH)
AF:
0.218
AC:
460
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1253
2506
3760
5013
6266
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
338
676
1014
1352
1690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.220
Hom.:
4823
Bravo
AF:
0.206
Asia WGS
AF:
0.189
AC:
657
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Spondyloepimetaphyseal dysplasia, aggrecan type Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Osteochondritis dissecans Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spondyloepiphyseal dysplasia, Kimberley type Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.15
DANN
Benign
0.92
PhyloP100
-6.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00011
dbscSNV1_RF
Benign
0.0020
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2280465; hg19: chr15-89417629; API